Abstract 1852P
Background
Oncology is a satisfying career. Helping patients through their cancer diagnosis and treatment can offer a sense of self fulfilment. But on the other hand, it can take its emotional toll on doctors. Long hours, dealing with life and death can affect oncologist’s mental health. It can cause depression, anxiety and PTSD. Our aim is to identify individuals who are at risk for burnout and facilitate interventions to prevent it.
Methods
This study used a descriptive design to identify individuals at risk for burnout among oncologists. It included 100 clinicians, working in various hospitals in Tunisia, recruited via email invitations. Inclusion criteria included being a practicing oncologist with at least one year of experience. Participants anonymously completed the Maslach Burnout Inventory (MBI) questionnaire, a tool used to detect burnout. The MBI consists of 22 items that assess emotional exhaustion, depersonalization, and personal accomplishment.
Results
The population is made of 77% females and 23% males. With an average age of 33 years, medical oncologists represented 80%, radiotherapists 12% and surgical oncologists 8%. The majority had professional experience ranging from 1 to 5 years. Gender difference was seen on the emotional exhaustion subscale where women scored higher. No significant differences were observed in the scores based on professional experience or field of practice. Emotional Exhaustion: Participants had a mean score of 29. Meaning the participants experienced high levels of emotional exhaustion. Only 20% of the population had low score, 20% scored moderately and 60% had high scores. Depersonalization: Results showed a mean score of 10. Participants are experiencing moderate levels of depersonalization, with 28% scoring low, 32% scoring moderate and 40% scoring high. Personal Accomplishment: the average score was 35. Participants are experiencing moderate levels of personal accomplishment, with 32% at low risk of burnout, 20% at moderate risk and 48% at high risk of burnout.
Conclusions
Our study provides valuable information about the levels of burnout experienced by oncologists. It should inform interventions and strategies to mitigate burnout and promote wellbeing in this population. It should also ring alarm bells to oncologists’ suffering mental health.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2018P - Novel nomogram based on the expression of DLL3 and PD-L1 for predicting the prognosis of small cell lung cancer patients
Presenter: Jun Zhao
Session: Poster session 05
2019P - Analysis of lung immune prognostic index (LIPI) score in a small cell lung cancer carcinoma (SCLC) cohort, supporting its prognostic use and investigating its predictive potential
Presenter: Mónica Esteban García
Session: Poster session 05
2020P - Circulating micro RNAs (cmiRNAs) as treatment outcome predictors in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab plus carboplatin and etoposide (ACE): CATS/ML43257 study
Presenter: Giulia Pasello
Session: Poster session 05
2021P - Cell-free (cf) DNA as predictive biomarker (B) of treatment outcome in extensive small cell lung cancer (eSCLC) patients (pts) receiving atezolizumab, carboplatin and etoposide (ACE): CATS/ML43257 study
Presenter: Giulia Pasello
Session: Poster session 05
2022P - ALBA project: Prognostic impact of laterality in small cell lung cancer
Presenter: Lorenza Landi
Session: Poster session 05
2024P - Supportive measures to control myelosuppression and costs for patients with SCLC with lurbinectedin, CAV or topotecan with or without trilaciclib: A review on the basis of clinical trials
Presenter: Manuel Dómine
Session: Poster session 05
2025P - Stratified control study of neuroendocrine differentiation and potential clinicopathologic markers
Presenter: Li Liu
Session: Poster session 05
2026P - Small cell lung cancer (SCLC) in the KBP-2020-CPHG cohort and comparison with 2000 and 2010
Presenter: Lionel Falchero
Session: Poster session 05
2027P - Immune checkpoint inhibitors in the treatment of small cell lung cancer: A systematic review and meta-analysis
Presenter: Patsy Lee
Session: Poster session 05